Search results
Tematy dnia
24 sie 2023 · Two new drugs—Eisai's Leqembi and Eli Lilly's donanemab—are showing promising results of slowing Alzheimer’s when the disease is in the early stages. Leqembi was approved by the...
18 lip 2023 · In a short time, decades of research has started to come to fruition, with at least three new drugs demonstrating the first glimmers of promise. The latest is called donanemab, with the findings of a global trial involving 1,700 patients presented at a major Alzheimer's conference in The Netherlands.
2 lip 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.
Researchers are preparing to test lecanemab with other experimental drugs, and how it works in high-risk people before they show the first signs of memory problems. An experimental Alzheimer’s...
5 wrz 2024 · In a recent breakthrough in Alzheimer’s disease research, Auburn University scientists have studied a new drug, troriluzole, that can prevent brain changes leading to memory loss and cognitive decline in a mouse model of the disease.
28 maj 2024 · A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression.
2 lip 2024 · WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
